KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Travere Therapeutics (TVTX) Inventory Average (2016 - 2025)

Historic Inventory Average for Travere Therapeutics (TVTX) over the last 12 years, with Q3 2025 value amounting to $4.8 million.

  • Travere Therapeutics' Inventory Average fell 2184.56% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year decrease of 2184.56%. This contributed to the annual value of $7.8 million for FY2024, which is 1203.62% up from last year.
  • As of Q3 2025, Travere Therapeutics' Inventory Average stood at $4.8 million, which was down 2184.56% from $4.0 million recorded in Q2 2025.
  • Over the past 5 years, Travere Therapeutics' Inventory Average peaked at $19.8 million during Q3 2023, and registered a low of $4.0 million during Q2 2025.
  • Its 5-year average for Inventory Average is $7.8 million, with a median of $7.0 million in 2021.
  • In the last 5 years, Travere Therapeutics' Inventory Average surged by 16484.02% in 2023 and then crashed by 6880.98% in 2024.
  • Over the past 5 years, Travere Therapeutics' Inventory Average (Quarter) stood at $7.0 million in 2021, then dropped by 15.14% to $5.9 million in 2022, then skyrocketed by 155.36% to $15.1 million in 2023, then crashed by 58.4% to $6.3 million in 2024, then decreased by 23.24% to $4.8 million in 2025.
  • Its Inventory Average stands at $4.8 million for Q3 2025, versus $4.0 million for Q2 2025 and $5.1 million for Q1 2025.